Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers H > Headlines for HTG Molecular Diagnostics, Inc. > News item |
HTG Molecular Diagnostics to conduct initial public offering of stock
Leerink Partners is the bookrunner; Canaccord Genuity, JMP to assist
By Devika Patel
Knoxville, Tenn., Dec. 31 – HTG Molecular Diagnostics, Inc. intends to price an initial public offering of its common stock with a 30-day greenshoe option, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.
Leerink Partners is the bookrunning manager. Canaccord Genuity and JMP Securities are the co-managers.
Proceeds will be used for clinical development, research and development, working capital and other general corporate purposes.
The Tucson company designs and markets a novel technology platform to facilitate the routine use of complex molecular profiling. The company intends to list its common stock on the Nasdaq under the symbol “HTGM.”
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.